Statement Of Cash Flows [Abstract]

Alligator Bioscience - Filing #679585

Concept 2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Interest paid, classified as operating activities
483,000 SEK
646,000 SEK
Interest received, classified as operating activities
1 883 SEK
0 SEK
Cash flows from (used in) operating activities
189 286 SEK
172 607 SEK
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities
2 459 SEK
440,000 SEK
Cash flows from (used in) investing activities
2 459 SEK
440,000 SEK
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares
195 097 SEK
380,000 SEK
Payments to acquire or redeem entity's shares
- SEK
380,000 SEK
Repayments of borrowings, classified as financing activities
- SEK
104,000 SEK
Payments of lease liabilities, classified as financing activities
9 754 SEK
7 806 SEK
Cash flows from (used in) financing activities
161 561 SEK
7 827 SEK
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
30 184 SEK
180 875 SEK
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
1 004 SEK
32,000 SEK
Cash and cash equivalents
66 118 SEK
97 305 SEK
278 148 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.